Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.
暂无分享,去创建一个
G. Parmiani | C. Gambacorti-Passerini | L. Rivoltini | F. Arienti | E. Pogliani | G. Corneo | A. Orazi | L. Borin